Tested.Traced.Released.

Acylated synthetic polypeptide supplied as a lyophilized reference standard. Presentation: freeze-dried powder, soluble in research-grade aqueous solvent. Supplied for in-vitro receptor binding assays, analytical method development, and reference standard comparison. Not for use in any living organism.

Acylated synthetic polypeptide supplied as a lyophilized reference standard. Presentation: freeze-dried powder, soluble in research-grade aqueous solvent. Supplied for in-vitro receptor binding assays, analytical method development, and reference standard comparison. Not for use in any living organism.

Acylated synthetic polypeptide supplied as a lyophilized reference standard. Presentation: freeze-dried powder, soluble in research-grade aqueous solvent. Supplied for in-vitro receptor binding assays, analytical method development, and reference standard comparison. Not for use in any living organism.

Acylated synthetic polypeptide supplied as a lyophilized reference standard. Presentation: freeze-dried powder, soluble in research-grade aqueous solvent. Supplied for in-vitro receptor binding assays, analytical method development, and reference standard comparison. Not for use in any living organism.

Substituted linear synthetic polypeptide supplied as a lyophilized reference standard. Presentation: freeze-dried powder, soluble in research-grade aqueous solvent. Supplied for in-vitro receptor binding assays, analytical method development, and reference standard comparison. Not for use in any living organism.

Cyclic heptapeptide of the melanocortin peptide class, closed by a lactam bridge between the Asp and Lys residues. The lactam ring gives a conformationally constrained structure relative to linear melanocortin peptides. Supplied as the acetate salt, lyophilized, for in-vitro research applications.

Cyclic synthetic polypeptide supplied as a lyophilized reference standard. Presentation: freeze-dried powder, soluble in research-grade aqueous solvent. Supplied for in-vitro receptor binding assays, analytical method development, and reference standard comparison. Not for use in any living organism.

Synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly (AEDG). Corresponds to a defined peptide fraction of the pineal extract epithalamin. Supplied as lyophilized powder for in-vitro research applications.

Synthetic 28-amino-acid N-terminally acetylated peptide corresponding to the thymosin alpha-1 fragment of prothymosin alpha. Spans residues 2-29 of the precursor sequence and was first described as a component of the thymic tissue extract thymosin fraction 5. Supplied as lyophilized powder for in-vitro research applications.

Synthetic 16-amino-acid mitochondrial-derived peptide encoded by a short open reading frame within the mitochondrial 12S rRNA gene. Grouped with humanin and the SHLP series in the mitochondrial-derived peptide family. Supplied as lyophilized powder for in-vitro research applications.

Thiol-bearing tripeptide composed of L-glutamate, L-cysteine and glycine, joined through a gamma-glutamyl amide bond. Reduced form (GSH), in which the cysteine thiol is free rather than disulfide-linked as in the oxidized dimer GSSG. Supplied as lyophilized powder for in-vitro research applications.

Terminally modified analog of the synthetic tetrapeptide epitalon (Ala-Glu-Asp-Gly), carrying an N-terminal acetyl group and a C-terminal amide. Both modifications neutralize the terminal charges present in the unmodified sequence. Supplied as lyophilized powder for in-vitro research applications.

Synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. Constructed as an analog of the endogenous tetrapeptide tuftsin extended at the C-terminus with a Pro-Gly-Pro motif. Supplied as lyophilized powder for in-vitro research applications.

Synthetic heptapeptide. Corresponds to the ACTH (4-10) fragment extended at the C-terminus with a Pro-Gly-Pro tripeptide. Supplied as lyophilized powder for in-vitro research applications.

Amidated decapeptide corresponding to the C-terminal fragment of kisspeptin-54, the KISS1 gene product. Covers residues 45-54 of the precursor and carries the RF-amide C-terminal motif characteristic of the kisspeptin family. Supplied as lyophilized powder for in-vitro research applications.

Synthetic pentadecapeptide with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Corresponds to a partial sequence of the human gastric protein BPC. Supplied as lyophilized powder for in-vitro research applications.

Synthetic peptide corresponding to thymosin beta-4, a naturally occurring 43-amino-acid polypeptide. The sequence includes the internal heptapeptide segment LKKTETQ. Supplied as the acetate salt, lyophilized, for in-vitro research applications.

Copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine. The copper ion is coordinated by the N-terminal amine, the adjacent amide nitrogen, and the histidine imidazole, giving a blue lyophilized solid. Supplied as lyophilized powder for in-vitro research applications.

Two-component peptide blend totaling 4mg per vial. Combines BPC 157, a synthetic pentadecapeptide, with TB500, a thymosin beta-4 derived peptide supplied as the acetate salt. Supplied as co-lyophilized powder for in-vitro research applications.

Two-component peptide blend totaling 10mg per vial. Combines BPC 157, a synthetic pentadecapeptide, with TB500, a thymosin beta-4 derived peptide supplied as the acetate salt. Supplied as co-lyophilized powder for in-vitro research applications.

Two-component blend of BPC-157, a synthetic pentadecapeptide corresponding to a partial sequence of human gastric juice protein BPC, and TB-500, supplied as thymosin beta-4 acetate. Co-lyophilized powder for in-vitro research applications.

Two-component blend of CJC-1295 without DAC, a substituted GHRH (1-29) analog, and ipamorelin, a synthetic pentapeptide, co-lyophilized in a single vial, for in-vitro research applications.

Three-component peptide blend combining the synthetic pentadecapeptide BPC 157, the copper-tripeptide complex GHK-Cu, and TB500, a synthetic fragment of thymosin beta-4. Supplied as co-lyophilized powder for in-vitro research applications.

Two-component co-lyophilized blend of acylated synthetic polypeptide reference standards. Presentation: freeze-dried powder, soluble in research-grade aqueous solvent. Supplied for in-vitro receptor binding assays and analytical method development. Not for use in any living organism.

Two-component co-lyophilized blend of acylated synthetic polypeptide reference standards. Presentation: freeze-dried powder, soluble in research-grade aqueous solvent. Supplied for in-vitro receptor binding assays and analytical method development. Not for use in any living organism.

Four-component peptide blend combining the synthetic pentadecapeptide BPC 157, the copper-tripeptide complex GHK-Cu, TB500 (a synthetic thymosin beta-4 fragment), and KPV, the C-terminal Lys-Pro-Val tripeptide of alpha-MSH. Supplied as co-lyophilized powder for in-vitro research applications.

Synthetic 29-amino-acid peptide corresponding to the GHRH (1-29) sequence, carrying four residue substitutions (D-Ala2, Gln8, Ala15, Leu27). Contains no drug affinity complex (DAC) linker, which distinguishes it from the DAC-conjugated form. Supplied as lyophilized powder for in-vitro research applications.

Substituted GHRH (1-29) analog bearing a drug affinity complex (DAC): a maleimidopropionyl group at the C-terminal lysine. The maleimide is a thiol-reactive handle used in covalent conjugation chemistry. Supplied as lyophilized powder for in-vitro research applications.

Synthetic polypeptide fragment supplied as a lyophilized reference standard. Presentation: freeze-dried powder, soluble in research-grade aqueous solvent. Supplied for in-vitro receptor binding assays, analytical method development, and reference standard comparison. Not for use in any living organism.

Recombinant 83-amino-acid analog of human insulin-like growth factor 1, carrying an arginine substitution at position 3 of the native sequence and a 13-residue N-terminal extension peptide. Supplied as lyophilized powder for in-vitro research applications.

Modified synthetic polypeptide supplied as a lyophilized reference standard. Presentation: freeze-dried powder, soluble in research-grade aqueous solvent. Supplied for in-vitro receptor binding assays, analytical method development, and reference standard comparison. Not for use in any living organism.

Synthetic pentapeptide with the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2. The sequence incorporates the non-proteinogenic residue 2-aminoisobutyric acid (Aib), two D-configured residues, and a C-terminal amide. Supplied as lyophilized powder for in-vitro research applications.

Linear anionic glycosaminoglycan built from repeating D-glucuronic acid and N-acetyl-D-glucosamine disaccharide units. Units are joined by alternating beta-1,4 and beta-1,3 glycosidic bonds, giving an unbranched polysaccharide chain. Supplied as lyophilized powder for in-vitro research applications.

Nicotinamide adenine dinucleotide, a pyridine dinucleotide composed of nicotinamide mononucleotide joined to adenosine monophosphate through a pyrophosphate linkage. Corresponds to the dinucleotide coenzyme that occurs naturally in living cells. Supplied as lyophilized powder for in-vitro research applications.